Plasma Advanced Glycation End Products Are Associated With Incident Cardiovascular Events in Individuals With Type 2 Diabetes: A Case-Cohort Study With a Median Follow-up of 10 Years (EPIC-NL)

Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity

(2013) Katrien HJ. Gaens et al.   CURRENT OPINION IN LIPIDOLOGY

The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1

(2013) M. G. A. van Eupen et al.   DIABETOLOGIA

Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype

(2013) Nordin M.J. Hanssen et al.   EUROPEAN HEART JOURNAL

Mild Oxidative Damage in the Diabetic Rat Heart Is Attenuated by Glyoxalase-1 Overexpression

(2013) Olaf Brouwers et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Plasma Levels of Advanced Glycation Endproducts Nϵ-(carboxymethyl)lysine, Nϵ-(carboxyethyl)lysine, and Pentosidine Are not Independently Associated With Cardiovascular Disease in Individuals With or Without Type 2 Diabetes: The Hoorn and CODAM Studies

(2013) Nordin M. J. Hanssen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Molecular Basis of Arterial Stiffening: Role of Glycation – A Mini-Review

(2012) David R. Sell et al.   GERONTOLOGY

Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study

(2011) J. W. Nin et al.   DIABETES CARE

Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalist Study

(2011) J. K. Sun et al.   DIABETES CARE

Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology

(2011) A. K. Berner et al.   DIABETOLOGIA

Fat Mass Is Inversely Associated with Serum Carboxymethyl-Lysine, An Advanced Glycation End Product, in Adults

(2011) Richard D. Semba et al.   JOURNAL OF NUTRITION

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

(2010) A. M. D. Watson et al.   DIABETOLOGIA

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress

(2010) O. Brouwers et al.   DIABETOLOGIA

Overexpression of Glyoxalase-I Reduces Hyperglycemia-induced Levels of Advanced Glycation End Products and Oxidative Stress in Diabetic Rats

(2010) Olaf Brouwers et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women

(2009) Bente K. Kilhovd et al.   ATHEROSCLEROSIS

Validity of coronary heart diseases and heart failure based on hospital discharge and mortality data in the Netherlands using the cardiovascular registry Maastricht cohort study

(2009) Audrey H. H. Merry et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Cohort Profile: The EPIC-NL study

(2009) J. W. J. Beulens et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection

(2009) Jean L.J.M. Scheijen et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Plasma Carboxymethyl-Lysine, an Advanced Glycation End Product, and All-Cause and Cardiovascular Disease Mortality in Older Community-Dwelling Adults

(2009) Richard D. Semba et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study

(2009) Paul E. Norman et al.   JOURNAL OF VASCULAR SURGERY